Pompecki R, Shively J E, Todd C W
Cancer Res. 1981 May;41(5):1905-9.
Blood group determinants have been found in five carcinoembryonic antigen (CEA) preparations with a lectin and antibody-binding assay using polyethylene glycol 6000 to separate free from bound radiolabeled antigen. The assay described gives excellent sensitivity for the binding or inhibition of binding of various lectins or antibodies to CEA. One of the CEA preparations investigated has an A1 determinant, another has a B determinant, and all have H, Lea, Leb, and MN blood group determinants. In addition, all of the preparations tested bound concanavalin A. These findings are consistent with the idea that incomplete or unexpected glycosylation patterns occur in glycoproteins produced by tumor cells. Since antibodies directed against blood group substances cross react with carbohydrate determinants on CEA, clinical determinations of CEA or anti-CEA levels in serum may be adversely affected.
通过使用聚乙二醇6000从结合的放射性标记抗原中分离游离抗原的凝集素和抗体结合测定法,在五种癌胚抗原(CEA)制剂中发现了血型决定簇。所描述的测定法对各种凝集素或抗体与CEA的结合或结合抑制具有出色的灵敏度。所研究的一种CEA制剂具有A1决定簇,另一种具有B决定簇,并且所有制剂都具有H、Lea、Leb和MN血型决定簇。此外,所有测试的制剂都能结合伴刀豆球蛋白A。这些发现与肿瘤细胞产生的糖蛋白中存在不完整或意外的糖基化模式这一观点一致。由于针对血型物质的抗体与CEA上的碳水化合物决定簇发生交叉反应,血清中CEA或抗CEA水平的临床测定可能会受到不利影响。